What is new in Phoenix 8.5?
了解 Phoenix 8.5 版本的最新进展和增强功能。Watch the webinar to learn…
Danielle Pillsbury2024 年 2 月 26 日
Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator
The Simcyp Simulator is a software platform for population physiologically-based pharmacokinetic (PBPK) modeling and simulation.…
Jim Gallagher2024 年 2 月 23 日
Streamlining Your NCA Workflow
准备递交的 PK 分析面临着许多数据和合规方面的挑战。To work efficiently,…
Danielle Pillsbury2024 年 1 月 18 日
Interlaboratory Variability in the Madin–Darby Canine Kidney Cell Proteome
Madin–Darby canine kidney (MDCK) cells are widely used to study epithelial cell functionality. Their low…
Danielle Pillsbury2023 年 6 月 28 日
Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program
Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…
Danielle Pillsbury2023 年 6 月 1 日
Using Modeling & Simulation to Develop a Dosing Regimen for a Bispecific Antibody for Pediatric Cancer
Bispecific antibodies are an emerging class of antibodies developed in recent years that provide new…
Danielle Pillsbury2023 年 1 月 23 日
Simcyp Simulator Helps Optimize Drug Dosing in Adults & Adolescents with Orphan Disease
全世界约有 400,000 名先天性肾上腺增生症（CAH）患者。Current therapy for CAH uses a…
Becca Bucci2022 年 6 月 6 日
Bridging Formulations of Quetiapine for Children with Schizophrenia or Bipolar Disorder
Quetiapine is an atypical antipsychotic for treating schizophrenia, bipolar depression, bipolar mania that helps to…
Jim Gallagher2021 年 8 月 26 日
Aripiprazole lauroxil: PBPK for Dosing Regimen and DDI Identification
Aripiprazole lauroxil (Aristada®) was approved by the FDA for treating schizophrenia in adults in October…
Jim Gallagher2021 年 8 月 12 日
